CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19

NCT04575038 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

115

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Infection

Interventions

DRUG: Brequinar
DRUG: Placebo

Sponsor

Clear Creek Bio, Inc.